Lipigon Pharmaceuticals (Sweden) Market Value
| LPGO Stock | SEK 0.17 0.01 6.25% |
| Symbol | Lipigon |
Lipigon Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lipigon Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lipigon Pharmaceuticals.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Lipigon Pharmaceuticals on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Lipigon Pharmaceuticals AB or generate 0.0% return on investment in Lipigon Pharmaceuticals over 30 days. Lipigon Pharmaceuticals is related to or competes with Hansa Biopharma, Saniona AB, and Oncopeptides. Lipigon Pharmaceuticals AB develops drugs for lipid related diseases in Sweden More
Lipigon Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lipigon Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lipigon Pharmaceuticals AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 36.83 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 11.76 |
Lipigon Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipigon Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lipigon Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Lipigon Pharmaceuticals historical prices to predict the future Lipigon Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (1.79) | |||
| Treynor Ratio | (3.88) |
Lipigon Pharmaceuticals Backtested Returns
Lipigon Pharmaceuticals has Sharpe Ratio of -0.0694, which conveys that the firm had a -0.0694% return per unit of risk over the last 3 months. Lipigon Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lipigon Pharmaceuticals' Standard Deviation of 7.31, mean deviation of 5.0, and Risk Adjusted Performance of (0.05) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lipigon Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Lipigon Pharmaceuticals is expected to be smaller as well. At this point, Lipigon Pharmaceuticals has a negative expected return of -0.51%. Please make sure to verify Lipigon Pharmaceuticals' potential upside, kurtosis, and the relationship between the value at risk and skewness , to decide if Lipigon Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.55 |
Good reverse predictability
Lipigon Pharmaceuticals AB has good reverse predictability. Overlapping area represents the amount of predictability between Lipigon Pharmaceuticals time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lipigon Pharmaceuticals price movement. The serial correlation of -0.55 indicates that about 55.0% of current Lipigon Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Lipigon Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Lipigon Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lipigon Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Lipigon Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Lipigon Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lipigon Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lipigon Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lipigon Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lipigon Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Lipigon Pharmaceuticals Lagged Returns
When evaluating Lipigon Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lipigon Pharmaceuticals stock have on its future price. Lipigon Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lipigon Pharmaceuticals autocorrelation shows the relationship between Lipigon Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Lipigon Pharmaceuticals AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lipigon Stock Analysis
When running Lipigon Pharmaceuticals' price analysis, check to measure Lipigon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipigon Pharmaceuticals is operating at the current time. Most of Lipigon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lipigon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipigon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lipigon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.